Mississippi's Lung Cancer Hero

October 2nd 2022

Dr. Pierre de Delva works tirelessly to bring better outcomes to patients with lung cancer who live in Mississippi — a state that traditionally has poor lung cancer outcomes.

From Hair Loss to Menopause, a Look at the ‘Good Stuff’ From Cancer Treatment

October 1st 2022

Cancer tried to kill me, but I came back even stronger than ever.

Bringing Clarity to Ocular Melanoma: Patient Advocate Offers Ways Support Can Help Patients, Loved Ones

September 30th 2022

By Kristie L. Kahl

Melody Burchett, of A Cure In Sight, discussed the value of seeking support after an ocular melanoma diagnosis, and how such help can be found in others with the same diagnosis.

FDA Approves Lytgobi for Advanced Cholangiocarcinoma

September 30th 2022

By Brielle Benyon

The Food and Drug Administration approved Lytgobi for patients with previously treated advanced cholangiocarcinoma with FGFR2 gene rearrangements.

Novel Drug Decreases Fibrosis in Myelofibrosis, A Type of Blood Cancer

September 30th 2022

By Brielle Benyon

Treatment with the novel drug GB2064 was associated with decreased fibrosis in patients with myelofibrosis, a type of blood cancer, according to findings from an ongoing phase 2 trial.